StockData
Kalaris Therapeutics, Inc. logo

Kalaris Therapeutics, Inc. (KLRS) stock

KLRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.37−0.06 (-4.20%)

Close on Nov 18, 2026Market cap $32.61MP/E –Yield –

Kalaris Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kalaris Therapeutics's market cap was $45.23M on Nov 11, 2026, against $116.70M a year earlier. Over the last 5 years it ranged from $8.50M to $817.49M, with a median of $121.17M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$45.23M-71.3%
2025Dec 31, 2025$157.85M+225.6%
2024Dec 31, 2024$48.48M-37.4%
2023Dec 29, 2023$77.47M-83.7%
2022Dec 30, 2022$475.22M-41.9%
2021Dec 31, 2021$817.49M-65.5%
2020Dec 31, 2020$2.37B–

More Kalaris Therapeutics figures

See a number that looks wrong?